Literature DB >> 16452530

Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology.

V Rochira1, A Balestrieri, B Madeo, L Zirilli, A R M Granata, C Carani.   

Abstract

Male age-related bone loss is caused, at least in part, by hypogonadism that occurs with advancing age. The study of the effects of sex steroids on bone physiology in men has recently highlighted the central role of estrogens on bone pathophysiology. This review focuses on particular aspects of bone physiology and pathophysiology in aging men, noting both the similarities to and the differences from female counterparts. In particular, the role of sex steroids on bone sexual dimorphism in health and disease has been analyzed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16452530     DOI： 10.1530/eje.1.02088

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


  23 in total

Review 1.  Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis.

Authors:  I Peter; M D Crosier; M Yoshida; S L Booth; L A Cupples; B Dawson-Hughes; D Karasik; D P Kiel; J M Ordovas; T A Trikalinos
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

2.  Lack of biochemical hypogonadism in elderly Arab males with low bone mineral density disease.

Authors:  Haider M Al Attia; Krishnasamy Jaysundaram; Fouad Saraj
Journal:  Rheumatol Int       Date:  2009-06-12       Impact factor: 2.631

Review 3.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

4.  Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.

Authors:  D Santi; B Madeo; F Carli; S Zona; G Brigante; F Vescini; G Guaraldi; V Rochira
Journal:  Osteoporos Int       Date:  2015-10-28       Impact factor: 4.507

5.  High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass.

Authors:  Lina E Aguirre; Georgia Colleluori; Kenneth E Fowler; Irum Zeb Jan; Kenneth Villareal; Clifford Qualls; David Robbins; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Eur J Endocrinol       Date:  2015-08       Impact factor: 6.664

6.  Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.

Authors:  Carlo Doria; Paolo Tranquilli Leali; Federico Solla; Gianluca Maestretti; Massimo Balsano; Robero Mario Scarpa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

7.  Response of trabecular bone, thyroid C and follicular cells to synthetic salmon calcitonin in middle-aged orchidectomized male rats.

Authors:  Branko Filipović; Branka Šošić-Jurjević; Vladimir Ajdžanović; Jasmina Živanović; Nataša Ristić; Svetlana Trifunović; Verica Milošević
Journal:  J Anat       Date:  2017-02-20       Impact factor: 2.610

8.  Lack of sexual dimorphism in femora of the eusocial and hypogonadic naked mole-rat: a novel animal model for the study of delayed puberty on the skeletal system.

Authors:  M Pinto; K J Jepsen; C J Terranova; R Buffenstein
Journal:  Bone       Date:  2009-09-15       Impact factor: 4.398

Review 9.  Aromatase deficiency in men: a clinical perspective.

Authors:  Vincenzo Rochira; Cesare Carani
Journal:  Nat Rev Endocrinol       Date:  2009-08-25       Impact factor: 43.330

Review 10.  The osteoporotic male: overlooked and undermanaged?

Authors:  Bruno Madeo; Lucia Zirilli; Giovanni Caffagni; Chiara Diazzi; Alessia Sanguanini; Elisa Pignatti; Cesare Carani; Vincenzo Rochira
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.